Site Search

Media

Insights and News

Filter by type:

FDB Approval for Aseptic Drug Product Fill/Finish - Therapeutic Fill Finish Production
News

Ensuring Access to Life-Saving Vaccine & Therapeutic Fill Finish Production

Immediate COVID-19 Vaccine & Therapeutic Fill Finish Production Availability Announced by Argonaut Manufacturing Services Advanced Facility Readies to Combat COVID-19 (Carlsbad, CA) March 23, 2020 – Argonaut Manufacturing Services announced today it has immediate availability for aseptic drug product manufacturing fill/finish service. Argonaut will provide services for Pre-clinical to Phase

Read More

FDB Approval for Aseptic Drug Product Fill/Finish - Therapeutic Fill Finish Production
News

Argonaut Proudly Hosting BIO International Ecosystem Tour in San Diego

Open Biopharma and Argonaut Manufacturing Services selected to host BIO International Ecosystem Tour in North County, San Diego CARLSBAD, CA, Mar. 3, 2020 Open Biopharma Research and Training Institute and Argonaut Manufacturing Services announced today their selection as a Biotech Ecosystem Tour for the 2020 BIO International Convention. Ecosystem Tours

Read More

FDB Approval for Aseptic Drug Product Fill/Finish - Therapeutic Fill Finish Production
News

Argonaut Manufacturing Services and Particle Measuring Systems Partnering for Top Tier Results

Providing customers with high standards – Particle Measuring Systems (PMS) and Argonaut Manufacturing Services partnering Partnership leverages their individual strengths to achieve high quality, reliable drug product manufacturing. February 25, 2020 – Argonaut Manufacturing Services, a contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Particle Measuring Systems (PMS), a

Read More

aseptic drug product manufacturing
News

Argonaut Manufacturing Services announces launch of aseptic drug product manufacturing services

Argonaut Manufacturing Services announces launch of aseptic drug product manufacturing services New introduction supports industry shortage of high-yield filling service providers CARLSBAD, CA – Argonaut Manufacturing Services, a premier contract development and manufacturing organization (CDMO) for biopharma, has announced the recent launch of their state-of-the-art aseptic drug product manufacturing vial

Read More

Minimize API loss fill/finish line
Blog Post

How to Minimize API Loss: A Case Study in Aseptic Fill/Finish

With API (active pharmaceutical ingredient) values continuing to climb as production scales conversely drop, it is time to rethink our aseptic filling processes to minimize API loss. The rise in biologics and personalized medicine has led to APIs with significant upstream production costs, where even the smallest loss of API

Read More

News

Mark O’Donnell Joins Argonaut Manufacturing Services Board

Argonaut Manufacturing Services Announces Mark O’Donnell as Addition to Board of Directors Carlsbad, CA, Nov 05, 2019 – Argonaut Manufacturing Services announced today that Mark O’Donnell has been appointed to the company’s Board of Directors. Mark O’Donnell joins the Argonaut Board with over 40 years of experience in global operations.

Read More

make vs buy in fill/finish manufacturing
Blog Post

The Make Versus Buy Dilemma: Evaluating your Aseptic Fill/Finish Manufacturing Strategy

Every biopharma company is eventually faced with the “make versus buy” decision – should they do the fill/finish manufacturing of their drug product in-house or outsource? Complicating things further, a third option also exists to outsource a portion while retaining some internal capabilities. For most companies, the choice to make

Read More

precision medicine
Blog Post

New manufacturing strategies for the precision medicine future

Blockbuster drugs and one-size-fits-all treatments now share portfolio space with highly targeted therapies for smaller patient populations. This new era is an opportunity for savvy companies to create greater value, both for patients and themselves. Yet, while precision medicine offers many financial advantages to pharmaceutical manufacturers, the increased cost of

Read More

Whitepaper

Pharma Supply Chain: CDMOs, Blockchain & Distributed Ledger Technologies (DLT)

Linking the Pharma Supply Chain The term blockchain is most often associated with cryptocurrencies such as Bitcoin, but the technology and its implications could have a more far-reaching impact on other industries including pharmaceutical manufacturing. Contract drug manufacturing organizations (CDMOs) and pharmaceutical developers could realize tangible benefits by implementing a

Read More

BIO International 2019
Blog Post

Our top picks for BIO International 2019

The BIO International 2019 conference is only one week away! Here at Argonaut, our team is preparing for a week filled with partnership meetings and exciting talks. This year a major conference focus is on rare diseases and precision medicine. With the packed programming schedule that BIO offers, it can

Read More

Load More